PCCA celebrated its inaugural formulation challenge, a research and development competition at International Seminar 2019. Here's the skinny: a patient problem. Five teams. 60 minutes. One winner. Click here to see who took the grand prize!

PCCA's Clinical Services team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a cornerstone of PCCA's abiding desire to provide pharmacies with answers to tough questions. The Clinical Services Spotlight is a limited series of articles designed to highlight a singular member of the Clinical Services team. This first article focuses on Andy Glasnapp, a Clinical Compounding Pharmacist, who for over twenty-five years has dedicated his life to helping people. Helping people by asking questions.

Cate Gregory has 25 years of experience combining hard business discipline with expertise in managing social complexity to achieve leadership and program success. She partners with Trusted Advisor Associates and The Get Real Project, where she leads their signature programs Being a Trusted Advisor, Trust-Based Selling, and Trust-Based Consulting. Cate will be one of the featured speakers at PCCA's International Seminar.

Congratulations to Tony Jones, RPh, owner of Pencol Compounding Pharmacy in Denver, Colorado for being our September Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of Pharmacy Compounding by providing the highest quality of service to their patients.

We have developed a robust system to ensure that we create and maintain over 9,000 formulas that provide PCCA members with what they need to compound high-quality, pharmaceutically elegant customized medications for their patients — all while complying with the latest standards in pharmacy compounding. But what does that look like? What’s in a PCCA formula? Let's take a closer look.

PCCA applauds the FDA for their decision and statement about Oxitriptan, which ensures that patients with BH4 deficiency can continue to receive the compounded medications they need.

Want some clarity on USP <797> and USP <800> updates? Our August updates to PCCA Play are designed to do just that with a free presentation from PCCA Education and Training Manager Jerra Banwarth, RPh, FIACP and Eagle President Ross Caputo, PhD. In another video, subscribers to PCCA Play can watch Eagle Vice President of Operations Megan Jeffrey Liotta, MS, discuss USP <797> regulation updates.

If you want to help your pharmacy stand out in a competitive field, it’s not enough to just say that you have quality products. Here are five ways that you can translate your investment in quality into your competitive advantage.

Congratulations to Stephen Anderson, RPh, of The Apothecary, Sartell, Minnesota for being our August Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of Pharmacy Compounding by providing the highest quality of service to their patients.

Compounders who use progesterone in their formulations are faced with the question, "Should I used micronized or wettable progesterone?" With the help of PCCA's Clinical Services team, we're here to help guide you through making the best decision in specific situations.